CONTACT LINKS PROJECT STAFF DISCLAIMER SEARCH
 
           
 
Presented by: UT El Paso / Austin Cooperative Pharmacy Program & Paso del Norte Health Foundation

Dr. José Rivera, principal investigator, was born in Barranquitas, Puerto Rico, completing his BS in Pharmacy from the University of Puerto Rico in May of 1976.  He received his Doctor of Pharmacy degree and a Pharmacy Residency Certificate from the University of Kentucky in June of 1979.  In the following years he worked in a clinical/academic setting at the University of Cincinnati and later at the University of New Mexico in Albuquerque.  He moved to El Paso in 1995 and served as Director of Pharmacy Services at Sierra Medical Center, and later as a Critical Care Pharmacist at R.E. Thomason General Hospital.  He was a Clinical Associate Professor with the UTEP Cooperative Pharmacy Program before becoming its director in January of 2001.  He is also Assistant Dean of the College of Pharmacy at UT Austin.

 

Aside from his involvement in academia, Dr. Rivera has extensive clinical experience, having worked in various trauma centers in the U.S.  He currently serves on a number of committees, including the Financial Aid, Honors & Awards, Residence, and College Steering Committees at the University of Texas at Austin and is a member of the El Paso City/County Board of Health. 

 

Throughout his career, he has presented at numerous local, state, and national conferences in both the pharmacy and medical fields.  He has also published a number of articles as a result of his extensive involvement in research.  He is currently involved in various clinical research projects with UTEP, the Paso Del Norte Health Foundation, Thomason Hospital, and various drug companies, looking at the use of herbal products and medications on the border as well as issues in critical care and antibiotic therapy.

 

Dr. Rivera’s present goals include to increase the number of pharmacists graduating from the program, to offer students in El Paso the opportunity to enter the field of pharmacy, and to continue conducting research related to healthcare in the border population.